b lynne parshall ionis pharmaceuticals inc chief operating officer  redbooks brands marketers agencies search less sell more    sign in get a free trial    contact us   b lynne parshall chief operating officer ionis pharmaceuticals inc email realtime sales trigger feed  generated by redbooks machine learning and natural language processing technology tracking  news sources to aggregate all new executives jobrole changes and news on decision makers brands and agencies in the mediamarketing industry this sales feed is for b lynne parshall at ionis pharmaceuticals inc b lynne parshall works as chief operating officer  acting in a executive management role  ionis pharmaceuticals inc is a leader in pharmaceuticals  health care products  redbooks tracks personnel changes for advertisers spending over  million annually for more executive management leads or mediamarketing prospecting automation start a free trial now recent related news  isis pharmaceuticals earns  million milestone payment from astrazeneca for isisar rx to treat prostate cancer  ar is a wellvalidated target in prostate cancer and our antisense approach may allow us to avoid the limitations of other therapeutic approaches that others have tried to inhibit this target said b lynne parshall chief operating officer at isis astrazenecas extensive experience in successfully developing and commercializing drugs to treat hormonerelated cancers like prostate cancer is a significant advantage for program success  people in this article b lynne parshall  brett monia  ionis pharmaceuticals inc nasdaqions files an k submission of matters to a vote of security holders  berthelsen    b lynne parshall    joseph h wender    the companys stockholders elected the foregoing candidates by affirmative votes by a majority of the votes of the shares  people in this article b lynne parshall learn more about b lynne parshall and  key contacts   create targeted lead lists   gain insider knowledge with advanced machine  learning   realtime verified contact info enter work email please enter email address please enter valid email address learn more about b lynne parshall and  key contacts first name  please enter first name last name  please enter last name company name  please enter company name email  phone  please enter phone number please enter  digits number what industry are you in    please select one the categories below please enter value for the industry  media sales  production  adtechmartech  sponsorship sales   agency new business   other what is your role    please select one the categories below please enter value for the role   csuite   vpmanager   sales rep   other thank you for registering for a free redbookscom trial we are processing your request and will be in touch shortly to get you started for immediate assistance please call us at   or email us at inforedbookscom home learn more free trial features ad think events thought leadership events top advertiser directory top agency directory add your agency update your agency agency showcase advertising associations creative spotlight services and suppliers about us blog contact us jobs terms  conditions privacy policy customer support   connect with us copyright   red books llc all rights reserved parshall b lynne  the wall street transcript b lynne parshall b lynne parshall is director executive vice president and chief financial officer of isis pharmaceuticals she is responsible for overseeing the operations of development chemistry manufacturing and pharmaceutics finance legal patent affairs and is also very involved in the company’s investor relations and business development activities ms parshall has been with isis for  years previously ms parshall was a partner with the firm of cooley godward llp where she represented several health care companies in a general practice specializing in corporate partnering and other technologybased transactions ms parshall received her jd at stanford law school stanford california and her ba from harvard university cambridge massachusetts ms parshall is currently a member of the board of trustees of the bishop’s school and the surf soccer board of directors she is also a member of the licensing executives society and a member of the american californian and san diego bar associations related interviewsblynne parshall  isis pharmaceuticals inc isisoctober   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu   wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google lynne b parshall chief executive officer and chief operating officer ionis pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person lynne b parshall chief executive officer and chief operating officer at ionis pharmaceuticals location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop lynne b parshall chief executive officer and chief operating officer at ionis pharmaceuticals location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop ms parshall is director and chief operating officer of isis pharmaceuticals she is responsible for overseeing the operations of finance legal patents manufacturing information technology regulatory and alliance management health and safety facilities corporate communications and business and corporate development ms parshall joined isis in november  previously ms parshall was a partner with the firm of cooley godward llp now cooley llp where she represented several health care companies in a general practice specializing in corporate partnering and other technologybased transactions ms parshall received her jd at stanford law school stanford california and her ba from harvard university cambridge massachusetts ms parshall is currently on the board of regulus therapeutics inc a company cofounded by isis and cytokinetics inc ms parshall is also a member of the licensing executives society and a member of the american california and san diego bar associations  companies in career na related markets  colleagues na related investments alias na industry rd in biotech environmental and various industries no marketing product yet tags biotechnology topics of influence na na careers achievements investments related people edit view all lynne b parshallcareer  nov ionis pharmaceuticals chief executive officer and chief operating officer  to  cooley llp partner competencies edit view all lynne b parshalleducation  stanford university harvard university edit lynne b parshallachievements and recognitions add milestone no milestones has been recorded for lynne b parshall edit lynne b parshalllinks add link no links has been recorded for lynne b parshall lynne b parshallinvestmentsacquisitions no investments has been recorded for lynne b parshall lynne b parshallinvestments representing others no investment reps has been recorded for lynne b parshall lynne b parshallrelated people colleagues at ionis pharmaceuticals stanley t crooke founder chairman and chief executive officer view all lynne b parshallrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies b lynne parshall esq  ionis pharmaceuticals b lynne parshall esq director  chief operating officer ms parshall is director and chief operating officer of ionis pharmaceuticals she is responsible for overseeing the operations of finance legal patents manufacturing information technology regulatory and alliance management health and safety facilities corporate communications and business and corporate development ms parshall joined ionis in november  previously ms parshall was a partner with the firm of cooley godward llp now cooley llp where she represented several health care companies in a general practice specializing in corporate partnering and other technologybased transactions ms parshall received her jd at stanford law school stanford california and her ba from harvard university cambridge massachusetts ms parshall is currently on the board of cytokinetics inc ms parshall is also a member of the licensing executives society and a member of the american california and san diego bar associations about mission  values in the community management board of directors contact patients patient resources clinical trials drug approval process learn more about ionis’ clinical trials pipeline rd antisense technology discovery platform basic science antisense drugs medicinal chemistry antisense approaches intellectual property strategic alliances pharmaceutical partners satellite companies investors  media news  events press releases archived webcasts event calendar corporate governance board of directors board criteria director compensation and board meeting attendance committee composition certificates of incorporation bylaws code of ethics clawback policy rsu holding guidelines annual meeting stock information stock quote stock chart analyst coverage ownership profile financials annual reports sec filings shareholder services investor faq information request press kit careers available positions search open jobs browse open jobs edit your profile view submitted applications culture  values benefits equal opportunity intern program postdoctoral program   coo of ionis pharmaceuticals nasdaqions parshall b lynne sells  shares worth  stay connected latest posts in rss businessentertainmentfeatured newsfeatured press releasefinancehealthlifestylenationnon firstpageoriginalpress releasereviewshoppingsportsstockstechnologytravelworld latest comments in rss  empowerednews world news summary helping you stay informed business finance sports entertainment health technology travel shopping our writers about us privacy policy contact us advertise press releases coo of ionis pharmaceuticals nasdaqions parshall b lynne sells  shares worth  according to ionis pharmaceuticalss most recent form  filing with the sec dated mar   pm company coo parshall b lynne disclosed selling  shares at a cost of  at the time of this transaction mar  this trade was worth  in total as of mar  parshall b lynne now owns  shares in total worth about  for the last few recent trades made by ionis pharmaceuticals nasdaqions coo parshall b lynne we have the following information sec form  filing jan  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of jan  were  sec form  filing dec  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of dec  were  sec form  filing dec  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of dec  were  posted by george daniels on thursday march    pm edt all trademarks acknowledged filed under stocks comments and trackbacks closed follow responses rss  comments are closed latest news evp clao of vertex pharmaceuticals incorpor nasdaqvrtx parini michael sells  shares worth  ceo  president of vertex pharmaceuticals incorpor nasdaqvrtx leiden jeffrey m sells  shares worth  evp gmda cmo of vertex pharmaceuticals incorpor nasdaqvrtx chodakewitz jeffrey sells  shares worth  evp global research and cso of vertex pharmaceuticals incorpor nasdaqvrtx altshuler david sells  shares worth  evpchief commercial officer of vertex pharmaceuticals incorpor nasdaqvrtx arbuckle stuart a sells  shares worth  see remarks of aimmune therapeutics nasdaqaimt sheehy douglas t sells  shares worth  svp and general counsel of nxstage medical nasdaqnxtm swan winifred l sells  shares worth  chief product officer of facebook nasdaqfb cox christopher k sells  shares worth  founder  executive chairman of ellie mae nyseelli anderman sigmund sells  shares worth  chief financial officer of civitas solutions nysecivi holler denis m sells  shares worth  news categories business  stocks  entertainment  featured news  featured press release  finance  health  lifestyle  nation  non firstpage  original  press release  review  shopping  sports  technology  travel  world  featured press releases  to  asiapacific shutoff valve market research analysis report  to  asiapacific rodenticide market research analysis report rubber tapes  global sales market report including key players achem  m rubber coatings  global sales market report including key players pro guard  cantech canada rigid intermediate bulk container ribc  global sales market report including key players greif inc  mondi group rapid prototyping machines  global sales market report including key players datron  roland dga reverse vending machine  global sales market report including key players tomra systems asa  wincornixdorf  to  asiapacific printer toner cartridge market research analysis report radiation shielding glass  global sales market report including key players electric glass building materials  raybloc quantum computing  global sales market report including key players microsoft  intel business finance sports entertainment health technology travel shopping about us contact us privacy policy advertise press releases terms of service log in b parshall ionis pharmaceuticals inc profile  biography  bloomberg feedback b parshall chief operating officer ionis pharmaceuticals inc career history chief operating officer ionis pharmaceuticals inc present chief operating officer isis pharmaceuticals inc  coosecretary isis pharmaceuticals inc  cfocoosecretary isis pharmaceuticals inc unknown exec vpcfocoosecy isis pharmaceuticals inc  exec vpcfosecretary isis pharmaceuticals inc  senior vpcfosecretary isis pharmaceuticals inc  senior vpsecretary isis pharmaceuticals inc  vpsecretary isis pharmaceuticals inc  partner cooley godward llp  isis pharmaceuticals inc  vpbusiness devlopment biotrack inc  exec vpcfocoo isis pharmaceuticals inc unknown show more website wwwionispharmacom corporate information address  gazelle court carlsbad ca  united states phone  fax  web url wwwionispharmacom from the web personal information education stanford law school jd  president  fellows of harvard college masters degree  harvard college bachelors degree show more awards  publications certificates bar admitted memberships board memberships ionis pharmaceuticals inc board member present akcea therapeutics inc board member present cytokinetics inc board member present isis pharmaceuticals inc board member  regulus therapeutics inc board member  cardiodynamics international corp board member  corautus genetics inc board member unknown show more other memberships california bar assn member san diego bar assn member american bar assn member bishops schl trustee licensing executives society member show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data b parshall  isis pharmaceuticals  inc  zoominfocom